Cite
HARVARD Citation
Bergquist, J. et al. (2016). Implications of CA19‐9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis. Journal of surgical oncology. 114 (4), pp. 475-482. [Online].